ASTER is a multi-part study that aims to prospectively establish evidence for the implementation of aromatherapy as complementary therapy within cancer care in the Singapore context. ASTER 2 study evaluates how extracts from Asian aromatic plants with familiar aromas introduced as inhalation therapy can alleviate distress in breast cancer patients scheduled to undergo radiotherapy (RT).
Aged 21 years old and above
Confirmed diagnosis of breast cancer of any stage
Scheduled to undergo radiotherapy for the first time
Capable of providing informed consent
Physically or mentally incapable of providing verbal/written consent
Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations
Airway hypersensitivity to fragrances, paint fumes or turpentine
Taking medications for anxiety (e.g. benzodiazepines) before radiotherapy